CoChat

A high-fat diet promotes depression-like behavior in mice by suppressing hypothalamic PKA signaling

Open access
Vagena, Eirini, Ryu, Jae Kyu, Baeza-Raja, Bernat, Walsh, Nicola M., Syme, Catriona, Day, Jonathan P., Houslay, Miles D., Baillie, George S. · 2019 · Translational Psychiatry
Cited by 132

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Obesity is associated with an increased risk of depression. The aim of the present study was to investigate whether obesity is a causative factor for the development of depression and what is the molecular pathway(s) that link these two disorders. Using lipidomic and transcriptomic methods, we identified a mechanism that links exposure to a high-fat diet (HFD) in mice with alterations in hypothalamic function that lead to depression. Consumption of an HFD selectively induced accumulation of palmitic acid in the hypothalamus, suppressed the 3′, 5′-cyclic AMP (cAMP)/protein kinase A (PKA) signaling pathway, and increased the concentration of free fatty acid receptor 1 (FFAR1). Deficiency of phosphodiesterase 4A (PDE4A), an enzyme that degrades cAMP and modulates stimulatory regulative G protein (Gs)-coupled G protein-coupled receptor signaling, protected animals either from genetic- or dietary-induced depression phenotype. These findings suggest that dietary intake of saturated fats disrupts hypothalamic functions by suppressing cAMP/PKA signaling through activation of PDE4A. FFAR1 inhibition and/or an increase of cAMP signaling in the hypothalamus could offer potential therapeutic targets to counteract the effects of dietary or genetically induced obesity on depression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41398-019-0470-1

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Research works printed but not linked: 55

  1. Jacobs, D. R. Jr. Fast food and sedentary lifestyle: a combination that leads to obesity. Am. J. Clin. Nutr. 83, 189–190 (2006). · DOI
  2. Hryhorczuk, C., Sharma, S. & Fulton, S. E. Metabolic disturbances connecting obesity and depression. Front. Neurosci. 7, 177 (2013). · DOI · Paper page
  3. Weber, B., Schweiger, U., Deuschle, M. & Heuser, I. Major depression and impaired glucose tolerance. Exp. Clin. Endocrinol. Diabetes. 108, 187–190 (2000). · DOI · Paper page
  4. Faith, M. S., Matz, P. E. & Jorge, M. A. Obesity-depression associations in the population. J. Psychosom. Res. 53, 935–942 (2002). · DOI · Paper page
  5. Shelton, R. C. The molecular neurobiology of depression. Psychiatr. Clin. North Am. 30, 1–11 (2007). · DOI · Paper page
  6. Nelson, J. C. A review of the efficacy of serotonergic and noradrenergic reuptake inhibitors for treatment of major depression. Biol. Psychiatry 46, 1301–1308 (1999). · DOI · Paper page
  7. Papakostas, G. I. et al. Obesity among outpatients with major depressive disorder. Int. J. Neuropsychopharmacol. 8, 59–63 (2005). · DOI · Paper page
  8. Perez, J., Tardito, D., Racagni, G., Smeraldi, E. & Zanardi, R. Protein kinase A and Rap1 levels in platelets of untreated patients with major depression. Mol. Psychiatry 6, 44–49 (2001). · DOI
  9. Ozawa, H. & Rasenick, M. M. Chronic electroconvulsive treatment augments coupling of the GTP-binding protein Gs to the catalytic moiety of adenylyl cyclase in a manner similar to that seen with chronic antidepressant drugs. J. Neurochem. 56, 330–338 (1991). · DOI · Paper page
  10. Perez, J., Tinelli, D., Bianchi, E., Brunello, N. & Racagni, G. cAMP binding proteins in the rat cerebral cortex after administration of selective 5-HT and NE reuptake blockers with antidepressant activity. Neuropsychopharmacology 4, 57–64 (1991).
  11. Nibuya, M., Nestler, E. J. & Duman, R. S. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neurosci. 16, 2365–2372 (1996). · DOI · Paper page
  12. Dell’Acqua, M. L. et al. Regulation of neuronal PKA signaling through AKAP targeting dynamics. Eur. J. Cell. Biol. 85, 627–633 (2006). · DOI · Paper page
  13. Maurice, D. H. et al. Advances in targeting cyclic nucleotide phosphodiesterases. Nat. Rev. Drug Discov. 13, 290–314 (2014). · DOI · Paper page
  14. Francis, S. H., Houslay, M. D. & Conti, M. Phosphodiesterase inhibitors: factors that influence potency, selectivity, and action. Handbook Exp. Pharmacol. 204, 47–84 (2011).
  15. Houslay, M. D. Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown. Trends Biochem. Sci. 35, 91–100 (2010). · DOI · Paper page
  16. Perez-Torres, S. et al. Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and[3H]rolipram binding autoradiography. Comparison with monkey and rat brain. J. Chem. Neuroanat. 20, 349–374 (2000). · DOI · Paper page
  17. Shakur, Y., Pryde, J. G. & Houslay, M. D. Engineered deletion of the unique N-terminal domain of the cyclic AMP-specific phosphodiesterase RD1 prevents plasma membrane association and the attainment of enhanced thermostability without altering its sensitivity to inhibition by rolipram. Biochem. J. 292(Pt 3), 677–686 (1993). · DOI
  18. Yarwood, S. J., Steele, M. R., Scotland, G., Houslay, M. D. & Bolger, G. B. The RACK1 signaling scaffold protein selectively interacts with the cAMP-specific phosphodiesterase PDE4D5 isoform. J. Biol. Chem. 274, 14909–14917 (1999). · DOI · Paper page
  19. Houslay, M. D., Baillie, G. S. & Maurice, D. H. cAMP-Specific phosphodiesterase-4 enzymes in the cardiovascular system: a molecular toolbox for generating compartmentalized cAMP signaling. Circ. Res. 100, 950–966 (2007). · DOI · Paper page
  20. Dziedzic, B., Szemraj, J., Bartkowiak, J. & Walczewska, A. Various dietary fats differentially change the gene expression of neuropeptides involved in body weight regulation in rats. J. Neuroendocrinol. 19, 364–373 (2007). · DOI · Paper page
  21. Huang, X. F., Xin, X., McLennan, P. & Storlien, L. Role of fat amount and type in ameliorating diet-induced obesity: insights at the level of hypothalamic arcuate nucleus leptin receptor, neuropeptide Y and pro-opiomelanocortin mRNA expression. Diabetes Obes. Metab. 6, 35–44 (2004). · DOI · Paper page
  22. Vangaveti, V., Shashidhar, V., Jarrod, G., Baune, B. T. & Kennedy, R. L. Free fatty acid receptors: emerging targets for treatment of diabetes and its complications. Ther. Adv. Endocrinol. Metab. 1, 165–175 (2010). · DOI · Paper page
  23. Briscoe, C. P. et al. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J. Biol. Chem. 278, 11303–11311 (2003). · DOI · Paper page
  24. Ang, Z. & Ding, J. L. GPR41 and GPR43 in obesity and inflammation - protective or causative? Front. Immunol. 7, 28 (2016). · DOI · Paper page
  25. Perry, S. J. et al. Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins. Science (New York, NY) 298, 834–836 (2002). · DOI · Paper page
  26. Miller, W. E. & Lefkowitz, R. J. Expanding roles for beta-arrestins as scaffolds and adapters in GPCR signaling and trafficking. Curr. Opin. Cell. Biol. 13, 139–145 (2001). · DOI · Paper page
  27. Richter, W. et al. Signaling from beta1- and beta2-adrenergic receptors is defined by differential interactions with PDE4. EMBO J. 27, 384–393 (2008). · DOI · Paper page
  28. Bornstein, S. R., Schuppenies, A., Wong, M. L. & Licinio, J. Approaching the shared biology of obesity and depression: the stress axis as the locus of gene-environment interactions. Mol. Psychiatry 11, 892–902 (2006). · DOI · Paper page
  29. MacKenzie, S. J. et al. Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A-mediated phosphorylation of a single serine residue in Upstream Conserved Region 1 (UCR1). Br. J. Pharmacol. 136, 421–433 (2002). · DOI · Paper page
  30. Di Benedetto, G. et al. Protein kinase A type I and type II define distinct intracellular signaling compartments. Circ. Res. 103, 836–844 (2008). · DOI · Paper page
  31. Houslay, K. F. et al. Identification of a multifunctional docking site on the catalytic unit of phosphodiesterase-4 (PDE4) that is utilised by multiple interaction partners. Biochem. J. 474, 597–609 (2017). · DOI
  32. Tyrrell, J. et al. Using genetics to understand the causal influence of higher BMI on depression. Int. J. Epidemiol. (2018). · DOI · Paper page
  33. Walsh, D. A., Perkins, J. P. & Krebs, E. G. An adenosine 3’,5’-monophosphate-dependant protein kinase from rabbit skeletal muscle. J. Biol. Chem. 243, 3763–3765 (1968). · DOI · Paper page
  34. Nestler, E. J., Terwilliger, R. Z. & Duman, R. S. Chronic antidepressant administration alters the subcellular distribution of cyclic AMP-dependent protein kinase in rat frontal cortex. J. Neurochem. 53, 1644–1647 (1989). · DOI · Paper page
  35. Zambon, A. C. et al. Gene expression patterns define key transcriptional events in cell-cycle regulation by cAMP and protein kinase A. Proc. Natl. Acad. Sci. USA 102, 8561–8566 (2005). · DOI
  36. Nicholas, D. A. et al. Palmitic acid is a Toll-like receptor 4 ligand that induces human dendritic cell secretion of IL-1beta. PLoS ONE 12, e0176793 (2017). · DOI
  37. Mazzola-Pomietto, P., Azorin, J. M., Tramoni, V. & Jeanningros, R. Relation between lymphocyte beta-adrenergic responsivity and the severity of depressive disorders. Biol. Psychiatry 35, 920–925 (1994). · DOI
  38. Maurice, D. H. et al. Cyclic nucleotide phosphodiesterase activity, expression, and targeting in cells of the cardiovascular system. Mol. Pharmacol. 64, 533–546 (2003). · DOI · Paper page
  39. Cherry, J. A. & Davis, R. L. Cyclic AMP phosphodiesterases are localized in regions of the mouse brain associated with reinforcement, movement, and affect. J. Comp. Neurol. 407, 287–301 (1999). · DOI · Paper page
  40. Zeller, E., Stief, H. J., Pflug, B. & Sastre-y-Hernandez, M. Results of a phase II study of the antidepressant effect of rolipram. Pharmacopsychiatry 17, 188–190 (1984). · DOI · Paper page
  41. Schneider, H. H. Brain cAMP response to phosphodiesterase inhibitors in rats killed by microwave irradiation or decapitation. Biochem. Pharmacol. 33, 1690–1693 (1984). · DOI
  42. Dyke, H. J. & Montana, J. G. Update on the therapeutic potential of PDE4 inhibitors. Expert Opin. Investig. Drugs 11, 1–13 (2002). · DOI · Paper page
  43. O’Donnell, J. M. & Zhang, H. T. Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4). Trends Pharmacol. Sci. 25, 158–163 (2004). · DOI · Paper page
  44. Murdoch, H. et al. Isoform-selective susceptibility of DISC1/phosphodiesterase-4 complexes to dissociation by elevated intracellular cAMP levels. J. Neurosci. 27, 9513–9524 (2007). · DOI · Paper page
  45. El Bawab, S. et al. Selective stimulation of a cAMP-specific phosphodiesterase (PDE4A5) isoform by phosphatidic acid molecular species endogenously formed in rat thymocytes. Eur. J. Biochem. 247, 1151–1157 (1997). · DOI
  46. Nemoz, G., Sette, C. & Conti, M. Selective activation of rolipram-sensitive, cAMP-specific phosphodiesterase isoforms by phosphatidic acid. Mol. Pharmacol. 51, 242–249 (1997). · DOI
  47. Hansen, R. T. 3rd, Conti, M. & Zhang, H. T. Mice deficient in phosphodiesterase-4A display anxiogenic-like behavior. Psychopharmacology 231, 2941–2954 (2014). · DOI
  48. Akinfiresoye, L. & Tizabi, Y. Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR. Psychopharmacology 230, 291–298 (2013). · DOI · Paper page
  49. Rodgers, R. J. & Dalvi, A. Anxiety, defence and the elevated plus-maze. Neurosci. Biobehav. Rev. 21, 801–810 (1997). · DOI · Paper page
  50. Gentleman, R. C. et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5, R80 (2004). · DOI · Paper page
  51. Passino, M. A., Adams, R. A., Sikorski, S. L. & Akassoglou, K. Regulation of hepatic stellate cell differentiation by the neurotrophin receptor p75NTR. Science (New York, NY) 315, 1853–1856 (2007). · DOI · Paper page
  52. Huston, E. et al. The cAMP-specific phosphodiesterase PDE4A5 is cleaved downstream of its SH3 interaction domain by caspase-3. Consequences for altered intracellular distribution. J. Biol. Chem. 275, 28063–28074 (2000). · DOI
  53. Sachs, B. D. et al. p75 neurotrophin receptor regulates tissue fibrosis through inhibition of plasminogen activation via a PDE4/cAMP/PKA pathway. J. Cell. Biol. 177, 1119–1132 (2007). · DOI · Paper page
  54. Marchmont, R. J. & Houslay, M. D. A peripheral and an intrinsic enzyme constitute the cyclic AMP phosphodiesterase activity of rat liver plasma membranes. Biochem. J. 187, 381–392 (1980). · DOI · Paper page
  55. Brunengraber, D. Z. et al. Influence of diet on the modeling of adipose tissue triglycerides during growth. Am. J. Physiol. Endocrinol. Metab. 285, E917–E925 (2003). · DOI · Paper page

Cited by

See all 132

Metadata

Authors
Vagena, E., Ryu, J. K., Baeza-Raja, B., Walsh, N. M., Syme, C., Day, J. P., Houslay, M. D., & Baillie, G. S.
Venue
Translational Psychiatry
Published
2019-05-10
Volume
9
Issue
1
Pages
141-141
ISSN
2158-3188 (ISSN-L)
OpenAlex
W2905210422
Cited by
132
References
18
FWCI
7.06
Type
journal article
Language
en
Open access
gold
Licence
Funders
RCUK | Medical Research Council (MR/J007412/1)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A high-fat diet promotes depression-like behavior in mice by suppressing hypothalamic PKA signaling. https://app.cochat.ai/papers/10.1038/s41398-019-0470-1
The paper
Vagena, E., Ryu, J. K., Baeza-Raja, B., Walsh, N. M., Syme, C., Day, J. P., Houslay, M. D., & Baillie, G. S. (2019). A high-fat diet promotes depression-like behavior in mice by suppressing hypothalamic PKA signaling. Translational Psychiatry. https://doi.org/10.1038/s41398-019-0470-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.